INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 11 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,298,000 | -10.7% | 7,500,000 | 0.0% | 0.11% | +11.6% |
| Q4 2019 | $8,171,000 | +9.8% | 7,500,000 | 0.0% | 0.10% | +1.1% |
| Q3 2019 | $7,439,000 | -0.3% | 7,500,000 | 0.0% | 0.09% | -3.1% |
| Q2 2019 | $7,461,000 | +622.3% | 7,500,000 | +650.0% | 0.10% | +646.2% |
| Q4 2016 | $1,033,000 | -24.2% | 1,000,000 | 0.0% | 0.01% | -35.0% |
| Q3 2016 | $1,362,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 7,700,000 | $8,592,000 | 1.03% |
| Bruce & Co., Inc. | 2,000,000 | $2,220,000 | 0.43% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 13,600,000 | $15,130,000 | 0.36% |
| Orbimed Advisors | 7,000,000 | $7,788,000 | 0.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $1,108,000 | 0.08% |
| Verition Fund Management LLC | 1,633,000 | $1,826,000 | 0.06% |
| Citadel Advisors | 11,250,000 | $12,462,000 | 0.01% |
| CREDIT SUISSE AG/ | 4,750,000 | $5,239,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |